Get complete Patent Opposition Report for Supernus Pharmaceuticals

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Explore Supernus Pharmaceuticals's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent NumberGrant DateTitleTotal Oppositions
EP2552210Dec 20, 2017Formulations Of Mazindol1
EP1589951Aug 9, 2017Use Of A Mixture Of Two Or More Enteric Materials To Regulate Drug Release Via Membrane Or Matrix For Systemic Therapeutics1